Melissa Seymour, MBA

Melissa Seymour, MBA

EVP and Chief Quality Officer at Eli Lilly

Eli Lilly and Company•Raleigh, North Carolina, United States

View LinkedIn Profile
Experience33+ Years
LevelCXO

Executive Overview

Seasoned Quality and business professional with 20+ years of experience in GMP, GCP, GLP and PV functions within pharma and biotech industries. Seeking board level positions to drive business performance. Specialties: External Auditing, Quality Management Systems, Change Control, Regulatory Inspections, Risk Management, Global Systems Implementations

Career Timeline

Professional employment history
  • Jul 2024–Present· 2 yrs 3 mos
    • Executive Vice President, Chief Quality Officer, Eli Lilly and CompanyCurrent
      Jul 2024–Present
  • Oct 2022–Jul 2024· 1 yr 9 mos
    • Chief Quality Officer
      Oct 2022–Jul 2024
  • 2002–Oct 2022· 20 yrs 9 mos
    • Chief Quality Officer
      2021–Oct 2022
    • Vice President, Global Quality Control
      Nov 2015–2021
    • Vice President, Corporate Quality
      Feb 2013–Nov 2015
    • Sr. Director, Corporate GxP Compliance and Quality Systems
      2002–Feb 2013
  • Jul 1995–2002· 6 yrs 6 mos
    • Manager, Quality Assurance
      Jul 1995–2002
  • 1995–2002· 7 yrs
    • Manager, Quality Assurance
      1995–2002
  • Sep 1993–Jul 1995· 1 yr 10 mos
    • Quality Auditor/ Technical Writer
      Sep 1993–Jul 1995

Education

Global Executive MBA

Business

Duke University - The Fuqua School of Business

BS

Biochemistry, Biological Sciences

North Carolina State University

Executive Relationship Map

Reports To
Melissa Seymour, MBA
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
GxPRegulatory AffairsSopComputer System ValidationTechnology TransferRisk ManagementChange Control21 CFR Part 11Quality SystemCAPAGMPExternal AuditFDAMedical DevicesV&VValidationQuality AssurancePharmaceutical IndustryInspectionBiotechnology